Albers Jeffrey W. bought KYMR
October 13, 2025 · Form 4 insider transaction
Albers Jeffrey W. bought 5,000 shares of Kymera Therapeutics, Inc. at $10.34 per share, a transaction worth $51.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$10.34
Total value
$51.7K
InsiderAlbers Jeffrey W.
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 13, 2025
Filing dateOctober 14, 2025
Shares owned after5,000
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 20, 2024 adopted by the reporting person.